紫杉醇洗脱球囊和西罗莫司洗脱球囊，对抗共同敌人的众多武器：支架内再狭窄。 - Suppr | 超能文献

Paclitaxel eluting balloon and sirolimus eluting balloon, many weapons against a common enemy: The in-stent restenosis.

作者信息

Piraino Davide

机构信息

Interventional Cardiology, "P.Giaccone" Universitary Hospital of Palermo, Italy.

出版信息

Int J Cardiol. 2017 Sep 1;242:4. doi: 10.1016/j.ijcard.2017.03.035.

DOI:10.1016/j.ijcard.2017.03.035

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Paclitaxel eluting balloon and sirolimus eluting balloon, many weapons against a common enemy: The in-stent restenosis.紫杉醇洗脱球囊和西罗莫司洗脱球囊，对抗共同敌人的众多武器：支架内再狭窄。

Int J Cardiol. 2017 Sep 1;242:4. doi: 10.1016/j.ijcard.2017.03.035.

2

Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.西罗莫司洗脱支架或紫杉醇洗脱支架与球囊血管成形术预防冠状动脉支架内再狭窄患者复发的随机对照试验。

JAMA. 2005 Jan 12;293(2):165-71. doi: 10.1001/jama.293.2.165.

3

Restenosis in a Bare-Metal Stent: Drug-Eluting Balloon or Drug-Eluting Stent?裸金属支架再狭窄：药物洗脱球囊还是药物洗脱支架？

Circ Cardiovasc Interv. 2016 Apr;9(4):e003829. doi: 10.1161/CIRCINTERVENTIONS.116.003829.

4

Crush stenting with paclitaxel-eluting or sirolimus-eluting stents for the treatment of coronary bifurcation lesions.使用紫杉醇洗脱支架或西罗莫司洗脱支架进行挤压式支架置入术治疗冠状动脉分叉病变。

Angiology. 2008 Aug-Sep;59(4):475-83. doi: 10.1177/0003319707312519. Epub 2008 Apr 2.

5

Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels.紫杉醇和西罗莫司洗脱支架在小冠状动脉血管中的随机试验。

Eur Heart J. 2006 Feb;27(3):260-6. doi: 10.1093/eurheartj/ehi721. Epub 2006 Jan 9.

6

Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.紫杉醇洗脱支架或西罗莫司洗脱支架预防糖尿病患者再狭窄

N Engl J Med. 2005 Aug 18;353(7):663-70. doi: 10.1056/NEJMoa044372. Epub 2005 Aug 16.

7

Letter by Alfonso et al Regarding Article, "Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study".阿方索等人就文章《紫杉醇洗脱球囊导管与依维莫司洗脱支架治疗冠状动脉支架内再狭窄的疗效比较：支架内再狭窄治疗研究》所写的信。

Circ Cardiovasc Interv. 2016 Sep;9(9). doi: 10.1161/CIRCINTERVENTIONS.116.004098.

8

Response by Pleva et al to Letter Regarding Article, "Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study".普莱瓦等人对关于“紫杉醇洗脱球囊导管与依维莫司洗脱支架治疗冠状动脉支架内再狭窄疗效比较：支架内再狭窄治疗研究”一文的信件的回复

Circ Cardiovasc Interv. 2016 Sep;9(9). doi: 10.1161/CIRCINTERVENTIONS.116.004304.

9

Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.紫杉醇涂层球囊联合裸金属支架与雷帕霉素洗脱支架治疗初发病变：一项血管内超声研究。

EuroIntervention. 2012 Aug;8(4):450-5. doi: 10.4244/EIJV8I4A71.

10

Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.西罗莫司洗脱支架与紫杉醇洗脱支架治疗冠状动脉初发病变的随机对照试验：REALITY试验

JAMA. 2006 Feb 22;295(8):895-904. doi: 10.1001/jama.295.8.895.

引用本文的文献

1

Catlet scoring system as a new predictor for in-stent restenosis in patients with chronic coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent.卡特利评分系统作为接受药物洗脱支架经皮冠状动脉介入治疗的慢性冠状动脉疾病患者支架内再狭窄的一种新预测指标。

J Cardiothorac Surg. 2025 Jan 29;20(1):106. doi: 10.1186/s13019-025-03349-2.

2

Significant difference between sirolimus and paclitaxel nanoparticles in anti-proliferation effect in normoxia and hypoxia: The basis of better selection of atherosclerosis treatment.西罗莫司和紫杉醇纳米颗粒在常氧和缺氧条件下抗增殖作用的显著差异：动脉粥样硬化治疗更佳选择的依据

Bioact Mater. 2020 Oct 1;6(3):880-889. doi: 10.1016/j.bioactmat.2020.09.005. eCollection 2021 Mar.